{"id":"W2957727389","doi":"10.1016/j.clcc.2019.07.003","title":"ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK","year":2019,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Cilag; Janssen Biotech; Merck Sharp and Dohme; National Institute for Health and Care Research; Roche; National Institute for Health Research Southampton Biomedical Research Centre; Sanofi; MedImmune; Merck; Institute of Cancer Research; Celgene; Bayer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Royal Marsden NHS Foundation Trust; Amgen","keywords":"Bevacizumab; Medicine; Colorectal cancer; Oncology; Observational study; Acorn; Chemotherapy; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003830154,0.0002536761,0.001095689,0.0001120342,0.00004601201,0.000007061809,0.000124284,0.00007908944,0.0002030986],"category_scores_gemma":[0.0001009528,0.0001491738,0.0001790753,0.0005384712,0.0001472399,0.00005685937,0.00002106646,0.0001112244,9.125375e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004942046,"about_ca_system_score_gemma":0.0004594309,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002058631,"about_ca_topic_score_gemma":0.05846705,"domain_scores_codex":[0.9979398,0.0001169287,0.00088206,0.0004194441,0.0003906382,0.0002511229],"domain_scores_gemma":[0.997673,0.001443197,0.000360886,0.0001846275,0.0002912414,0.00004703354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02355608,0.007568739,0.9530087,0.0001381806,0.0006211495,0.000009228857,0.003406142,0.0003994915,0.0001261963,0.00004311177,0.00005470274,0.01106833],"study_design_scores_gemma":[0.03415176,0.04244639,0.9198181,0.0001694953,0.0003131622,0.000002428497,0.001346101,0.0007140277,0.0006325564,0.00008188852,0.0001858498,0.0001382542],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916648,0.0009855295,0.000004639841,0.001472955,0.0002305043,0.005366933,0.0001296612,0.000009362912,0.0001355842],"genre_scores_gemma":[0.9954429,0.00110363,0.0001028228,0.0001516287,0.00006923202,0.002974267,0.00003544603,0.00002421695,0.00009580861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05640842,"threshold_uncertainty_score":0.9587135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1272756648630156,"score_gpt":0.4255683273884547,"score_spread":0.2982926625254391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}